Inhaled aztreonam lysine for the treatment of deficits in health-related qualityof life in lung diseases

Details for Australian Patent Application No. 2008307268 (hide)

Owner Gilead Sciences, Inc.

Inventors Yeager, Melissa; Montgomery, Alan

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008307268

PCT Pub. Number WO2009/045706

Priority 60/997,072 01.10.07 US; 60/997,071 01.10.07 US

Filing date 15 September 2008

Wipo publication date 9 April 2009

International Classifications

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

15 April 2010 PCT application entered the National Phase

  PCT publication WO2009/045706 Priority application(s): WO2009/045706

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008307269-Dopant material for manufacturing solar cells

2008307267-Tubal ligation